2020
DOI: 10.1016/j.ijantimicag.2020.106085
|View full text |Cite
|
Sign up to set email alerts
|

A Critical Review of Cephalexin and Cefadroxil for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection in the Era of “Bad Bugs, Few Drugs”

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
10
1

Year Published

2021
2021
2025
2025

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 71 publications
0
10
1
Order By: Relevance
“…ALUTI is a common and frequent clinical disease with a high incidence, and patients often present with symptoms such as urinary frequency, urinary urgency, and painful urination; in severe cases, symptoms of systemic infection may occur, requiring reasonable antimicrobial therapy with antibacterial drugs [ 16 ]. Clinically, different antibacterial drugs are often taken for the treatment of different pathogenic bacteria, and among the treatments for UTI, antibiotics are definitely effective, but before the results of urine bacterial culture drug sensitivity are obtained, drugs can only be used based on clinical experience, which sometimes delays the treatment and prolongs the treatment time [ 17 , 18 ].…”
Section: Discussionmentioning
confidence: 99%
“…ALUTI is a common and frequent clinical disease with a high incidence, and patients often present with symptoms such as urinary frequency, urinary urgency, and painful urination; in severe cases, symptoms of systemic infection may occur, requiring reasonable antimicrobial therapy with antibacterial drugs [ 16 ]. Clinically, different antibacterial drugs are often taken for the treatment of different pathogenic bacteria, and among the treatments for UTI, antibiotics are definitely effective, but before the results of urine bacterial culture drug sensitivity are obtained, drugs can only be used based on clinical experience, which sometimes delays the treatment and prolongs the treatment time [ 17 , 18 ].…”
Section: Discussionmentioning
confidence: 99%
“…β-Lactam antibiotics have historically been considered second-or third-line agents for uncomplicated UTIs due to concerns over inferior efficacy based on trials published before the 2000s; however, these trials varied in treatment duration, selection of comparative antimicrobials, antibiotic dosing, and definition of UTI and clinical cure. 10 Sigurdsson et al 4 compared a 3-day regimen of amoxicillin therapy to a 3-day regimen of trimethoprim-sulfadiazine, and found amoxicillin to be less effective at eradication; however, this study determined therapeutic efficacy according to bacteriological findings and did not look at symptomatic improvement. Similarly, a 3-day regimen of amoxicillin-clavulanate (58% clinical cure rate) was not as effective as ciprofloxacin (77% clinical cure rate), even in women infected with susceptible urinary pathogens.…”
Section: Discussionmentioning
confidence: 99%
“…While this clinical success rate is slightly lower than previously published success rates of >90%, only 8.3% of patients returned for nonresolving symptoms, and of these, only 2 of the total 264 patients included in this study (0.8%) had a non-cefazolin-susceptible urinary pathogen. 10 It should be noted that clinical success even among patients who receive antibiotics is difficult to assess, as previous studies have shown that 25%-54.2% of uncomplicated UTIs will resolve spontaneously without antibiotics. 15 Of all the patients analyzed in this study, only 4.2% returned with nonresolving symptoms who had monomicrobial infections with cefazolinsusceptible urinary pathogens that should have been adequately treated with cephalexin therapy.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In continuation of our research, the current study reports the synthesis and use of several cephalexin Schiff bases as additives to enhance the photostability of PS when exposed to UV radiation. Cephalexin is a β-lactamase antibiotic that is mainly used to treat Gram-positive bacteria [ 33 ]. It is a solid with a high melting point, is very stable, and contains an aromatic moiety as well as heteroatoms (sulfur, oxygen, and nitrogen).…”
Section: Introductionmentioning
confidence: 99%